---  
layout: startup_page  
title: "PeproMene Bio"  
id: "pepromenebio.com"  
permalink: "/pepromenebiopepromenebio.com12192024/"  
website: "https://pepromenebio.com/"  
funding_round: ""  
funding_amount: "$11M"  
investors: "Institute for Follicular Lymphoma Innovation"  
about: "PeproMene Bio, Inc. is a clinical-stage biotech company focused on developing novel therapies for B-cell malignancies and autoimmune disorders. Their lead candidate, PMB-CT01 (BAFFR-CAR T cells), is in Phase 1 clinical trials for relapsed and refractory B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia. The company also develops BAFFR Bispecific T Cell Engager and BAFFR-CAR NK cells."  
markets: "Biotechnology, Oncology, Cell Therapy, Health Care"  
hq: "Irvine, California, United States"  
founded_year: "2016"  
linkedin: "https://www.linkedin.com/company/pepromene-bio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/pepromene-bio"  
pitchbook: "https://pitchbook.com/profiles/company/229632-40"  

date_display: "19-Dec-2024"  
date: "2024-12-19"

# SEO Optimization  
meta_title: "PeproMene Bio -  Funding ($11M)"  
meta_description: "PeproMene Bio, PeproMene Bio, Inc. is a clinical-stage biotech company focused on developing novel therapies for B-cell malignancies and autoimmune disorders. Their ..."  
meta_keywords: "PeproMene Bio, Biotechnology, Oncology, Cell Therapy, Health Care,  funding"  
canonical_url: "https://startup.projectstartups.com/pepromenebiopepromenebio.com12192024/"  
---